https://www.selleckchem.com/
When patients were further stratified according to tumor size, better RFS and OS were observed in patients with small (≤ 5 cm) tumors after AR (P 0.001 and P = 0.004, respectively). Multivariate analysis identified AR (P = 0.024) as an independent favorable prognostic factor for RFS in HCC patients with BDTT. AR is recommended for HCC patients with BDTT, especially in patients with small (≤ 5 cm) tumors. AR is recommended for HCC patients with BDTT, especially in patients with small (≤ 5 cm) tumors.Coronavirus Disease 2019 is predominantly a disorder o
Like
Comment
Share
